Study of the collagen type VI alpha 3 (COL6A3) gene in Parkinson's disease

To date, the genetic contribution to Parkinson's disease (PD) remains unclear. Mutations in the collagen type VI alpha 3 (COL6A3) gene were recently identified as a cause of isolated dystonia. Since PD and dystonia are closely related disorders with shared clinical and genetic characteristics,...

Full description

Saved in:
Bibliographic Details
Published inBMC neurology Vol. 21; no. 1; p. 187
Main Authors Jin, Chong-Yao, Zheng, Ran, Lin, Zhi-Hao, Xue, Nai-Jia, Chen, Ying, Gao, Ting, Yan, Yi-Qun, Fang, Yi, Yan, Ya-Ping, Yin, Xin-Zhen, Tian, Jun, Pu, Jia-Li, Zhang, Bao-Rong
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 08.05.2021
BioMed Central
BMC
Subjects
Age
COL6A3
Collagen
Development and progression
Dystonia
Gene
Gene frequency
Gene mutations
Genes
Genetic aspects
Genetic screening
Genomes
Health aspects
Movement disorders
Muscular dystrophy
Mutation
Neurodegenerative diseases
Neurological research
Parkinson's disease
Pathogenicity
Patients
Proteins
China
COL6A3
Dystonia
Gene
Parkinson’s disease
Online AccessGet full text

Cover

Abstract To date, the genetic contribution to Parkinson's disease (PD) remains unclear. Mutations in the collagen type VI alpha 3 (COL6A3) gene were recently identified as a cause of isolated dystonia. Since PD and dystonia are closely related disorders with shared clinical and genetic characteristics, we explored the association between COL6A3 and PD in a Chinese cohort. We performed genetic screening of COL6A3 in a Chinese cohort of 173 patients with sporadic PD and 200 healthy controls. We identified variants that are likely to have pathogenic effects based on: 1) a minor allele frequency of < 0.01; and 2) the variant being recognized as deleterious by at least 15 different in silico predicting tools. Finally, we tested the aggregate burden of COL6A3 on PD via SKAT-O analysis. First, we found compound heterozygous COL6A3 gene mutations in one early-onset PD patients. Then, we explored whether COL6A3 variants contributed to increased risk of developing PD in a Chinese population. We detected 21 rare non-synonymous variants. Pathogenicity predictions identified 7 novel non-synonymous variants as likely to be pathogenic. SKAT-O analysis further revealed that an aggregate burden of variants in COL6A3 contributes to PD (p = 0.038). An increased aggregate burden of the COL6A3 gene was detected in patients with PD.
AbstractList To date, the genetic contribution to Parkinson's disease (PD) remains unclear. Mutations in the collagen type VI alpha 3 (COL6A3) gene were recently identified as a cause of isolated dystonia. Since PD and dystonia are closely related disorders with shared clinical and genetic characteristics, we explored the association between COL6A3 and PD in a Chinese cohort. We performed genetic screening of COL6A3 in a Chinese cohort of 173 patients with sporadic PD and 200 healthy controls. We identified variants that are likely to have pathogenic effects based on: 1) a minor allele frequency of < 0.01; and 2) the variant being recognized as deleterious by at least 15 different in silico predicting tools. Finally, we tested the aggregate burden of COL6A3 on PD via SKAT-O analysis. First, we found compound heterozygous COL6A3 gene mutations in one early-onset PD patients. Then, we explored whether COL6A3 variants contributed to increased risk of developing PD in a Chinese population. We detected 21 rare non-synonymous variants. Pathogenicity predictions identified 7 novel non-synonymous variants as likely to be pathogenic. SKAT-O analysis further revealed that an aggregate burden of variants in COL6A3 contributes to PD (p = 0.038). An increased aggregate burden of the COL6A3 gene was detected in patients with PD.
To date, the genetic contribution to Parkinson's disease (PD) remains unclear. Mutations in the collagen type VI alpha 3 (COL6A3) gene were recently identified as a cause of isolated dystonia. Since PD and dystonia are closely related disorders with shared clinical and genetic characteristics, we explored the association between COL6A3 and PD in a Chinese cohort. We performed genetic screening of COL6A3 in a Chinese cohort of 173 patients with sporadic PD and 200 healthy controls. We identified variants that are likely to have pathogenic effects based on: 1) a minor allele frequency of < 0.01; and 2) the variant being recognized as deleterious by at least 15 different in silico predicting tools. Finally, we tested the aggregate burden of COL6A3 on PD via SKAT-O analysis. First, we found compound heterozygous COL6A3 gene mutations in one early-onset PD patients. Then, we explored whether COL6A3 variants contributed to increased risk of developing PD in a Chinese population. We detected 21 rare non-synonymous variants. Pathogenicity predictions identified 7 novel non-synonymous variants as likely to be pathogenic. SKAT-O analysis further revealed that an aggregate burden of variants in COL6A3 contributes to PD (p = 0.038). An increased aggregate burden of the COL6A3 gene was detected in patients with PD.
Abstract Background To date, the genetic contribution to Parkinson’s disease (PD) remains unclear. Mutations in the collagen type VI alpha 3 (COL6A3) gene were recently identified as a cause of isolated dystonia. Since PD and dystonia are closely related disorders with shared clinical and genetic characteristics, we explored the association between COL6A3 and PD in a Chinese cohort. Methods We performed genetic screening of COL6A3 in a Chinese cohort of 173 patients with sporadic PD and 200 healthy controls. We identified variants that are likely to have pathogenic effects based on: 1) a minor allele frequency of < 0.01; and 2) the variant being recognized as deleterious by at least 15 different in silico predicting tools. Finally, we tested the aggregate burden of COL6A3 on PD via SKAT-O analysis. Results First, we found compound heterozygous COL6A3 gene mutations in one early-onset PD patients. Then, we explored whether COL6A3 variants contributed to increased risk of developing PD in a Chinese population. We detected 21 rare non-synonymous variants. Pathogenicity predictions identified 7 novel non-synonymous variants as likely to be pathogenic. SKAT-O analysis further revealed that an aggregate burden of variants in COL6A3 contributes to PD (p = 0.038). Conclusion An increased aggregate burden of the COL6A3 gene was detected in patients with PD.
Background To date, the genetic contribution to Parkinson's disease (PD) remains unclear. Mutations in the collagen type VI alpha 3 (COL6A3) gene were recently identified as a cause of isolated dystonia. Since PD and dystonia are closely related disorders with shared clinical and genetic characteristics, we explored the association between COL6A3 and PD in a Chinese cohort. Methods We performed genetic screening of COL6A3 in a Chinese cohort of 173 patients with sporadic PD and 200 healthy controls. We identified variants that are likely to have pathogenic effects based on: 1) a minor allele frequency of < 0.01; and 2) the variant being recognized as deleterious by at least 15 different in silico predicting tools. Finally, we tested the aggregate burden of COL6A3 on PD via SKAT-O analysis. Results First, we found compound heterozygous COL6A3 gene mutations in one early-onset PD patients. Then, we explored whether COL6A3 variants contributed to increased risk of developing PD in a Chinese population. We detected 21 rare non-synonymous variants. Pathogenicity predictions identified 7 novel non-synonymous variants as likely to be pathogenic. SKAT-O analysis further revealed that an aggregate burden of variants in COL6A3 contributes to PD (p = 0.038). Conclusion An increased aggregate burden of the COL6A3 gene was detected in patients with PD. Keywords: Parkinson's disease, Dystonia, Gene, COL6A3
Abstract Background To date, the genetic contribution to Parkinson’s disease (PD) remains unclear. Mutations in the collagen type VI alpha 3 ( COL6A3 ) gene were recently identified as a cause of isolated dystonia. Since PD and dystonia are closely related disorders with shared clinical and genetic characteristics, we explored the association between COL6A3 and PD in a Chinese cohort. Methods We performed genetic screening of COL6A3 in a Chinese cohort of 173 patients with sporadic PD and 200 healthy controls. We identified variants that are likely to have pathogenic effects based on: 1) a minor allele frequency of < 0.01; and 2) the variant being recognized as deleterious by at least 15 different in silico predicting tools. Finally, we tested the aggregate burden of COL6A3 on PD via SKAT-O analysis. Results First, we found compound heterozygous COL6A3 gene mutations in one early-onset PD patients. Then, we explored whether COL6A3 variants contributed to increased risk of developing PD in a Chinese population. We detected 21 rare non-synonymous variants. Pathogenicity predictions identified 7 novel non-synonymous variants as likely to be pathogenic. SKAT-O analysis further revealed that an aggregate burden of variants in COL6A3 contributes to PD ( p  = 0.038). Conclusion An increased aggregate burden of the COL6A3 gene was detected in patients with PD.
BACKGROUNDTo date, the genetic contribution to Parkinson's disease (PD) remains unclear. Mutations in the collagen type VI alpha 3 (COL6A3) gene were recently identified as a cause of isolated dystonia. Since PD and dystonia are closely related disorders with shared clinical and genetic characteristics, we explored the association between COL6A3 and PD in a Chinese cohort. METHODSWe performed genetic screening of COL6A3 in a Chinese cohort of 173 patients with sporadic PD and 200 healthy controls. We identified variants that are likely to have pathogenic effects based on: 1) a minor allele frequency of < 0.01; and 2) the variant being recognized as deleterious by at least 15 different in silico predicting tools. Finally, we tested the aggregate burden of COL6A3 on PD via SKAT-O analysis. RESULTSFirst, we found compound heterozygous COL6A3 gene mutations in one early-onset PD patients. Then, we explored whether COL6A3 variants contributed to increased risk of developing PD in a Chinese population. We detected 21 rare non-synonymous variants. Pathogenicity predictions identified 7 novel non-synonymous variants as likely to be pathogenic. SKAT-O analysis further revealed that an aggregate burden of variants in COL6A3 contributes to PD (p = 0.038). CONCLUSIONAn increased aggregate burden of the COL6A3 gene was detected in patients with PD.
Background To date, the genetic contribution to Parkinson’s disease (PD) remains unclear. Mutations in the collagen type VI alpha 3 (COL6A3) gene were recently identified as a cause of isolated dystonia. Since PD and dystonia are closely related disorders with shared clinical and genetic characteristics, we explored the association between COL6A3 and PD in a Chinese cohort. Methods We performed genetic screening of COL6A3 in a Chinese cohort of 173 patients with sporadic PD and 200 healthy controls. We identified variants that are likely to have pathogenic effects based on: 1) a minor allele frequency of < 0.01; and 2) the variant being recognized as deleterious by at least 15 different in silico predicting tools. Finally, we tested the aggregate burden of COL6A3 on PD via SKAT-O analysis. Results First, we found compound heterozygous COL6A3 gene mutations in one early-onset PD patients. Then, we explored whether COL6A3 variants contributed to increased risk of developing PD in a Chinese population. We detected 21 rare non-synonymous variants. Pathogenicity predictions identified 7 novel non-synonymous variants as likely to be pathogenic. SKAT-O analysis further revealed that an aggregate burden of variants in COL6A3 contributes to PD (p = 0.038). Conclusion An increased aggregate burden of the COL6A3 gene was detected in patients with PD.
ArticleNumber 187
Audience Academic
Author Jin, Chong-Yao
Chen, Ying
Xue, Nai-Jia
Zhang, Bao-Rong
Yan, Ya-Ping
Tian, Jun
Pu, Jia-Li
Yan, Yi-Qun
Yin, Xin-Zhen
Gao, Ting
Lin, Zhi-Hao
Zheng, Ran
Fang, Yi
Author_xml – sequence: 1
  givenname: Chong-Yao
  surname: Jin
  fullname: Jin, Chong-Yao
  organization: Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310009, People's Republic of China
– sequence: 2
  givenname: Ran
  surname: Zheng
  fullname: Zheng, Ran
  organization: Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310009, People's Republic of China
– sequence: 3
  givenname: Zhi-Hao
  surname: Lin
  fullname: Lin, Zhi-Hao
  organization: Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310009, People's Republic of China
– sequence: 4
  givenname: Nai-Jia
  surname: Xue
  fullname: Xue, Nai-Jia
  organization: Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310009, People's Republic of China
– sequence: 5
  givenname: Ying
  surname: Chen
  fullname: Chen, Ying
  organization: Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310009, People's Republic of China
– sequence: 6
  givenname: Ting
  surname: Gao
  fullname: Gao, Ting
  organization: Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310009, People's Republic of China
– sequence: 7
  givenname: Yi-Qun
  surname: Yan
  fullname: Yan, Yi-Qun
  organization: Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310009, People's Republic of China
– sequence: 8
  givenname: Yi
  surname: Fang
  fullname: Fang, Yi
  organization: Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310009, People's Republic of China
– sequence: 9
  givenname: Ya-Ping
  surname: Yan
  fullname: Yan, Ya-Ping
  organization: Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310009, People's Republic of China
– sequence: 10
  givenname: Xin-Zhen
  surname: Yin
  fullname: Yin, Xin-Zhen
  organization: Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310009, People's Republic of China
– sequence: 11
  givenname: Jun
  surname: Tian
  fullname: Tian, Jun
  organization: Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310009, People's Republic of China
– sequence: 12
  givenname: Jia-Li
  surname: Pu
  fullname: Pu, Jia-Li
  email: jialipu@zju.edu.cn
  organization: Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310009, People's Republic of China. jialipu@zju.edu.cn
– sequence: 13
  givenname: Bao-Rong
  surname: Zhang
  fullname: Zhang, Bao-Rong
  email: brzhang@zju.edu.cn
  organization: Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310009, People's Republic of China. brzhang@zju.edu.cn
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33964895$$D View this record in MEDLINE/PubMed
BookMark eNptUttuEzEQtVARbQM_wAOyxAPlYYtva3tfkKKIS1CkInF5tbz2bOKwscN6g5S_x2lKaRCyfNHMOWc8o3OJzmKKgNBzSq4p1fJNpkxrXhFGy2a0rtQjdEGFohXjSp09eJ-jy5zXhFClBX2CzjlvpNBNfYE-fRl3fo9Th8cVYJf63i4h4nG_Bfx9jm2_XVnM8dXsZiGn_DUuScAh4s92-BFiTvFVxj5ksBmeosed7TM8u7sn6Nv7d19nH6vFzYf5bLqoXC35WDEpVOO4apmXnXRKUKIVcdJL0kgAwhtW1x6AK9u1mkvPtWoJI1IS50E0fILmR12f7Npsh7Cxw94kG8xtIA1LY4cxuB5MQ50utQgULdFK1jjVOee1VgokdbJovT1qbXftBryDOA62PxE9zcSwMsv0y2hKJK3rInB1JzCknzvIo9mE7KCMMULaZcNqJrSuqT78--U_0HXaDbGM6oDSDRVCsr-opS0NhNilUtcdRM1USiq4IuWYoOv_oMrysAmu2KQLJX5CYEeCG1LOA3T3PVJiDm4yRzeZ4iZz6yajCunFw-ncU_7Yh_8GNFvCEw
CitedBy_id crossref_primary_10_3390_ijms24087435
crossref_primary_10_1186_s13024_024_00704_0
crossref_primary_10_3389_fnmol_2023_1232805
crossref_primary_10_1016_j_biopha_2022_113637
crossref_primary_10_3389_fnagi_2023_1207114
Cites_doi 10.1038/nature15393
10.1016/j.ajhg.2012.06.007
10.1016/s1474-4422(09)70068-7
10.1002/mds.870100413
10.1002/mds.26424
10.1016/j.braindev.2020.01.004
10.1371/journal.pgen.1005165
10.1016/S1474-4422(16)30230-7
10.1016/S1474-4422(11)70232-0
10.1212/WNL.37.6.1009
10.1101/531210%J
10.1002/mds.26501
10.1007/s10549-010-1295-z
10.1111/j.1432-1033.1984.tb08313.x
10.1186/s12859-017-1469-3
10.1007/s00415-006-7003-6
10.1038/nrneurol.2015.86
10.1016/j.jmb.2019.04.009
10.1016/j.ajhg.2015.04.010
10.1038/nprot.2015.053
10.1038/nprot.2015.105
10.1002/mds.25529
10.1038/nrneurol.2011.81
10.1016/j.ajhg.2011.05.029
10.1093/brain/awu179
10.1086/340608
10.1002/mds.25475
10.1038/nrdp.2017.13
10.1093/bioinformatics/btm404
10.1093/nar/gkx1039%J
10.1136/jmg.2002.002311
ContentType Journal Article
Copyright COPYRIGHT 2021 BioMed Central Ltd.
2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2021
Copyright_xml – notice: COPYRIGHT 2021 BioMed Central Ltd.
– notice: 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2021
DBID NPM
AAYXX
CITATION
3V.
7TK
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s12883-021-02215-7
DatabaseName PubMed
CrossRef
ProQuest Central (Corporate)
Neurosciences Abstracts
ProQuest_Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle PubMed
CrossRef
Publicly Available Content Database
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Neurosciences Abstracts
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest One Academic
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
PubMed


CrossRef
MEDLINE - Academic
Publicly Available Content Database
Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: 7X7
  name: Health & Medical Collection
  url: https://search.proquest.com/healthcomplete
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1471-2377
EndPage 187
ExternalDocumentID oai_doaj_org_article_91c89c30e7af4b629c7fccd8877e61c6
A661437014
10_1186_s12883_021_02215_7
33964895
Genre Journal Article
GeographicLocations China
GeographicLocations_xml – name: China
GroupedDBID ---
-A0
0R~
23N
2WC
3V.
53G
5VS
6J9
6PF
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AAWTL
ABDBF
ABIVO
ABUWG
ACGFO
ACGFS
ACIHN
ACPRK
ACRMQ
ADBBV
ADINQ
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C24
C6C
CCPQU
CS3
DIK
DU5
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
EMB
EMK
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IGS
IHR
INH
INR
ITC
KQ8
M1P
M48
M~E
NPM
O5R
O5S
OK1
P2P
PGMZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
TUS
UKHRP
W2D
WOQ
WOW
XSB
AAYXX
CITATION
ABVAZ
AFGXO
AFNRJ
7TK
7XB
8FK
AZQEC
DWQXO
K9.
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c563t-26479c37b2d6f6c7410870c6d6096ee039255dee37afb836d387b020660cde493
IEDL.DBID RPM
ISSN 1471-2377
IngestDate Tue Oct 22 15:16:41 EDT 2024
Tue Sep 17 21:27:06 EDT 2024
Sat Oct 26 00:12:02 EDT 2024
Thu Oct 10 19:27:41 EDT 2024
Thu Feb 22 23:27:37 EST 2024
Fri Feb 02 04:32:03 EST 2024
Thu Sep 12 18:21:20 EDT 2024
Sat Sep 28 08:37:19 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords COL6A3
Dystonia
Gene
Parkinson’s disease
Language English
License Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c563t-26479c37b2d6f6c7410870c6d6096ee039255dee37afb836d387b020660cde493
Notes ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106155/
PMID 33964895
PQID 2528914462
PQPubID 44772
PageCount 1
ParticipantIDs doaj_primary_oai_doaj_org_article_91c89c30e7af4b629c7fccd8877e61c6
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8106155
proquest_miscellaneous_2524885189
proquest_journals_2528914462
gale_infotracmisc_A661437014
gale_infotracacademiconefile_A661437014
crossref_primary_10_1186_s12883_021_02215_7
pubmed_primary_33964895
PublicationCentury 2000
PublicationDate 2021-05-08
PublicationDateYYYYMMDD 2021-05-08
PublicationDate_xml – month: 05
  year: 2021
  text: 2021-05-08
  day: 08
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle BMC neurology
PublicationTitleAlternate BMC Neurol
PublicationYear 2021
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References MA Larkin (2215_CR20) 2007; 23
LA Kelley (2215_CR21) 2015; 10
2215_CR29
AK Lampe (2215_CR27) 2005; 42
M Zech (2215_CR6) 2015; 96
F Carella (2215_CR11) 1993; 60
J Li (2215_CR19) 2017; 46
A Albanese (2215_CR8) 2013; 28
KR Chaudhuri (2215_CR4) 2009; 8
J Phukan (2215_CR13) 2011; 10
KJ Karczewski (2215_CR17) 2019; 1
S Chen (2215_CR15) 2017; 18
NE Mencacci (2215_CR14) 2014; 137
A Jochim (2215_CR28) 2016; 31
A Ascherio (2215_CR1) 2016; 15
W Poewe (2215_CR2) 2017; 3
RB Postuma (2215_CR3) 2015; 30
MC Wu (2215_CR24) 2011; 89
C Genomes Project (2215_CR18) 2015; 526
L Moutsianas (2215_CR32) 2015; 11
H Yang (2215_CR16) 2015; 10
SJ Frucht (2215_CR7) 2013; 28
S Lee (2215_CR31) 2012; 91
S Wijemanne (2215_CR12) 2015; 11
CG Bonnemann (2215_CR26) 2011; 7
A Ziegler (2215_CR23) 2011; 128
DER VON (2215_CR25) 1984; 142
D Kidron (2215_CR9) 1987; 37
A Ishikawa (2215_CR10) 1995; 10
E Tolosa (2215_CR30) 2006; 253
S Ittisoponpisan (2215_CR22) 2019; 431
E Demir (2215_CR5) 2002; 70
References_xml – volume: 526
  start-page: 68
  issue: 7571
  year: 2015
  ident: 2215_CR18
  publication-title: Nature.
  doi: 10.1038/nature15393
  contributor:
    fullname: C Genomes Project
– volume: 91
  start-page: 224
  issue: 2
  year: 2012
  ident: 2215_CR31
  publication-title: Am J Hum Genet
  doi: 10.1016/j.ajhg.2012.06.007
  contributor:
    fullname: S Lee
– volume: 8
  start-page: 464
  issue: 5
  year: 2009
  ident: 2215_CR4
  publication-title: Lancet Neurol
  doi: 10.1016/s1474-4422(09)70068-7
  contributor:
    fullname: KR Chaudhuri
– volume: 10
  start-page: 482
  issue: 4
  year: 1995
  ident: 2215_CR10
  publication-title: Mov Disord
  doi: 10.1002/mds.870100413
  contributor:
    fullname: A Ishikawa
– volume: 30
  start-page: 1591
  issue: 12
  year: 2015
  ident: 2215_CR3
  publication-title: Mov Disord
  doi: 10.1002/mds.26424
  contributor:
    fullname: RB Postuma
– ident: 2215_CR29
  doi: 10.1016/j.braindev.2020.01.004
– volume: 11
  start-page: e1005165
  issue: 4
  year: 2015
  ident: 2215_CR32
  publication-title: PLoS Genet
  doi: 10.1371/journal.pgen.1005165
  contributor:
    fullname: L Moutsianas
– volume: 15
  start-page: 1255
  issue: 12
  year: 2016
  ident: 2215_CR1
  publication-title: Lancet Neurol
  doi: 10.1016/S1474-4422(16)30230-7
  contributor:
    fullname: A Ascherio
– volume: 10
  start-page: 1074
  issue: 12
  year: 2011
  ident: 2215_CR13
  publication-title: Lancet Neurol
  doi: 10.1016/S1474-4422(11)70232-0
  contributor:
    fullname: J Phukan
– volume: 37
  start-page: 1009
  issue: 6
  year: 1987
  ident: 2215_CR9
  publication-title: Neurology
  doi: 10.1212/WNL.37.6.1009
  contributor:
    fullname: D Kidron
– volume: 1
  start-page: 531210
  year: 2019
  ident: 2215_CR17
  publication-title: BioRxiv
  doi: 10.1101/531210%J
  contributor:
    fullname: KJ Karczewski
– volume: 31
  start-page: 747
  issue: 5
  year: 2016
  ident: 2215_CR28
  publication-title: Mov Disord
  doi: 10.1002/mds.26501
  contributor:
    fullname: A Jochim
– volume: 128
  start-page: 197
  issue: 1
  year: 2011
  ident: 2215_CR23
  publication-title: Breast Cancer Res Treat
  doi: 10.1007/s10549-010-1295-z
  contributor:
    fullname: A Ziegler
– volume: 142
  start-page: 493
  issue: 3
  year: 1984
  ident: 2215_CR25
  publication-title: Eur J Biochem
  doi: 10.1111/j.1432-1033.1984.tb08313.x
  contributor:
    fullname: DER VON
– volume: 18
  start-page: 80
  issue: Suppl 3
  year: 2017
  ident: 2215_CR15
  publication-title: BMC Bioinform
  doi: 10.1186/s12859-017-1469-3
  contributor:
    fullname: S Chen
– volume: 253
  start-page: VII7
  issue: Suppl 7
  year: 2006
  ident: 2215_CR30
  publication-title: J Neurol
  doi: 10.1007/s00415-006-7003-6
  contributor:
    fullname: E Tolosa
– volume: 11
  start-page: 414
  issue: 7
  year: 2015
  ident: 2215_CR12
  publication-title: Nat Rev Neurol
  doi: 10.1038/nrneurol.2015.86
  contributor:
    fullname: S Wijemanne
– volume: 431
  start-page: 2197
  issue: 11
  year: 2019
  ident: 2215_CR22
  publication-title: J Mol Biol
  doi: 10.1016/j.jmb.2019.04.009
  contributor:
    fullname: S Ittisoponpisan
– volume: 96
  start-page: 883
  issue: 6
  year: 2015
  ident: 2215_CR6
  publication-title: Am J Hum Genet
  doi: 10.1016/j.ajhg.2015.04.010
  contributor:
    fullname: M Zech
– volume: 10
  start-page: 845
  issue: 6
  year: 2015
  ident: 2215_CR21
  publication-title: Nat Protoc
  doi: 10.1038/nprot.2015.053
  contributor:
    fullname: LA Kelley
– volume: 10
  start-page: 1556
  issue: 10
  year: 2015
  ident: 2215_CR16
  publication-title: Nat Protoc
  doi: 10.1038/nprot.2015.105
  contributor:
    fullname: H Yang
– volume: 28
  start-page: 884
  issue: 7
  year: 2013
  ident: 2215_CR7
  publication-title: Mov Disord
  doi: 10.1002/mds.25529
  contributor:
    fullname: SJ Frucht
– volume: 7
  start-page: 379
  issue: 7
  year: 2011
  ident: 2215_CR26
  publication-title: Nat Rev Neurol
  doi: 10.1038/nrneurol.2011.81
  contributor:
    fullname: CG Bonnemann
– volume: 89
  start-page: 82
  issue: 1
  year: 2011
  ident: 2215_CR24
  publication-title: Am J Hum Genet
  doi: 10.1016/j.ajhg.2011.05.029
  contributor:
    fullname: MC Wu
– volume: 137
  start-page: 2480
  issue: Pt 9
  year: 2014
  ident: 2215_CR14
  publication-title: Brain.
  doi: 10.1093/brain/awu179
  contributor:
    fullname: NE Mencacci
– volume: 70
  start-page: 1446
  issue: 6
  year: 2002
  ident: 2215_CR5
  publication-title: Am J Human Gen
  doi: 10.1086/340608
  contributor:
    fullname: E Demir
– volume: 28
  start-page: 863
  issue: 7
  year: 2013
  ident: 2215_CR8
  publication-title: Mov Disord
  doi: 10.1002/mds.25475
  contributor:
    fullname: A Albanese
– volume: 60
  start-page: 558
  year: 1993
  ident: 2215_CR11
  publication-title: J Neurol
  contributor:
    fullname: F Carella
– volume: 3
  start-page: 17013
  year: 2017
  ident: 2215_CR2
  publication-title: Nat Rev Dis Primers
  doi: 10.1038/nrdp.2017.13
  contributor:
    fullname: W Poewe
– volume: 23
  start-page: 2947
  issue: 21
  year: 2007
  ident: 2215_CR20
  publication-title: Bioinformatics (Oxford, England)
  doi: 10.1093/bioinformatics/btm404
  contributor:
    fullname: MA Larkin
– volume: 46
  start-page: D1039
  issue: D1
  year: 2017
  ident: 2215_CR19
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkx1039%J
  contributor:
    fullname: J Li
– volume: 42
  start-page: 673
  issue: 9
  year: 2005
  ident: 2215_CR27
  publication-title: J Med Genet
  doi: 10.1136/jmg.2002.002311
  contributor:
    fullname: AK Lampe
SSID ssj0017841
Score 2.3465166
Snippet To date, the genetic contribution to Parkinson's disease (PD) remains unclear. Mutations in the collagen type VI alpha 3 (COL6A3) gene were recently identified...
Abstract Background To date, the genetic contribution to Parkinson’s disease (PD) remains unclear. Mutations in the collagen type VI alpha 3 ( COL6A3 ) gene...
Background To date, the genetic contribution to Parkinson's disease (PD) remains unclear. Mutations in the collagen type VI alpha 3 (COL6A3) gene were recently...
Background To date, the genetic contribution to Parkinson’s disease (PD) remains unclear. Mutations in the collagen type VI alpha 3 (COL6A3) gene were recently...
BACKGROUNDTo date, the genetic contribution to Parkinson's disease (PD) remains unclear. Mutations in the collagen type VI alpha 3 (COL6A3) gene were recently...
Abstract Background To date, the genetic contribution to Parkinson’s disease (PD) remains unclear. Mutations in the collagen type VI alpha 3 (COL6A3) gene were...
SourceID doaj
pubmedcentral
proquest
gale
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 187
SubjectTerms Age
COL6A3
Collagen
Development and progression
Dystonia
Gene
Gene frequency
Gene mutations
Genes
Genetic aspects
Genetic screening
Genomes
Health aspects
Movement disorders
Muscular dystrophy
Mutation
Neurodegenerative diseases
Neurological research
Parkinson's disease
Pathogenicity
Patients
Proteins
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3BTtwwEB0hDohL1VLapoXKlZBoVUUkcTy2j1sEogjaS6m4WYntVblkUXc5cOM3-nv9Emac7GqjHrj0GjtS8mYmnhfPPAMclAE9UR-bN5a4Sa1bnVvTNLlumlZjbLRPQtqX3_Dsqj6_VtdrR31xTVgvD9wDd2RLb6yXRdTNtG6xsl5PvQ8UGzpi6Xux7cIuydSwf8C7acsWGYNH85IP1c25HIHWrFLlerQMJbX-f7_Ja4vSuGBybQU6fQ7PhtRRTPpHfgEbsduBrcthc_wlXHBN4L2YTQUldSIZmLxD8E9W8fOrSF21QoqPx98vcCI_CRqM4qYT3PicesD-PvyZi2HHZheuTk9-HJ_lw2EJuVcoF1yppgkn3VYBp-gpUSgoFD0GJJISY0F5kFIhRkk4tkZikEa3BYu5Fz7E2spXsNnNuvgGhMUyKNtWto66NgGNpSSN0gbmVjpUPoPPS-zcba-J4RKXMOh6pB0h7RLSTmfwheFdzWQ963SBrOwGK7unrJzBIRvHcdSRBXwzNA_QA7N-lZtwmiE18b0M9kYzKVr8eHhpXjdE69xVimgnE-Mqgw-rYb6TK9C6OLtLc-hbp0pjM3jde8PqlcjXsSaUMtAjPxm983iku_mVtLwNU3Kl3v4PkN7BdpVcXOWF2YPNxe-7uE8p06J9n6LjESbsD7g
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest_Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwEB5BkRAXxJtAQUZCAoSixkk8tk9oqagKauFC0d6sxPZCL0npbg_c-Bv8PX4JM17v0giJa-xI9rw8n-dhgOcyoCfoY8vOEjZpda9La7qu1F3Xa4yd9qmR9vFHPDxpP8zVPF-4LXNa5cYmJkMdRs935Hu1ImjA4KV-c_a95FejOLqan9C4CtdkXSGndOn5FnBJjqltCmUM7i0lP61bclICnVxSlXpyGKWe_f9a5ktH0zRt8tI5dHALbmYHUszWHL8NV-JwB64f5xD5XTjizMAfYlwIcu1EYjPJiOCrVvHlvUi1taIRL_c_HeGseSVoMIrTQXD5c6oE-_3z11LkuM09ODl493n_sMxPJpReYbPifDVtfaP7OuACPbkLFSmkx4AEVWKsyBtSKsTY6G7RmwZDY3RfcUv3yofY2uY-7AzjEB-CsCiDsn1t26hbE9BYctXIeWCEpUPtC3i9oZ07W3fGcAlRGHRrSjuitEuUdrqAt0ze7Uzuap0-jOdfXVYSZ6U3tPoq0uraHmvr9cL7QHZQR5QeC3jBzHGse8QB3-USAlowd7FyM3Y2Gk2or4DdyUzSGT8d3rDXZZ1dur8SVsCz7TD_yXloQxwv0hyyeEoaW8CDtTRst0QSjy1RqQA9kZPJnqcjw-m31NHbMDBX6tH_l_UYbtRJeFVZmV3YWZ1fxCfkEq36p0nu_wCI_waM
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Open Access Journals
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LixQxEC7WFcSL-LZ1lQiCirT2I6kkB5FxcVllVy-O7C10JxldkB6dmQX35t_w7_lLrMp0j9u4R6-dBJJ6pOrregTgURnQE_SxeWMJm0jd6tyapsl107QaY6N9aqR9-B73p_LdkTraguG5o56Ay3OhHb8nNV18ff7j--krUviXSeENvliW_GRuzskGZJFKlesLcLGShNQ5lU_-jSpwjG0onDl33cg4pR7-_97UZ0zVOI3yjF3auwpXeodSTNYScA22YncdLh32IfMbcMCZgqdiPhPk6onEdpIZwb9exae3ItXailo82f1wgJP6qaDBKI47weXQqTLs989fS9HHcW7CdO_Nx939vH9CIfcK6xXnr2nra91WAWfoyX0oSEE9BiToEmNB3pFSIcZaN7PW1Bhqo9uCW7wXPkRp61uw3c27eAeExTIo21ZWRi1NQGPJdSNnghGXDpXP4NlAO_dt3SnDJYRh0K0p7YjSLlHa6QxeM3k3M7nLdfowX3x2vdI4W3pDuy8i7U62WFmvZ94Huhd1xNJjBo-ZOY6lgzjgm76kgDbMXa3chJ2PWhMKzGBnNJN0yI-HB_a6QQRdpQiMMlyuMni4GeaVnJfWxflJmkM3oCqNzeD2Who2RyINQElUykCP5GR05vFId_wldfg2DNSVuvs_iHQPLldJxFVemB3YXi1O4n1ypFbtg6QdfwAdvhcJ
  priority: 102
  providerName: Scholars Portal
Title Study of the collagen type VI alpha 3 (COL6A3) gene in Parkinson's disease
URI https://www.ncbi.nlm.nih.gov/pubmed/33964895
https://www.proquest.com/docview/2528914462
https://search.proquest.com/docview/2524885189
https://pubmed.ncbi.nlm.nih.gov/PMC8106155
https://doaj.org/article/91c89c30e7af4b629c7fccd8877e61c6
Volume 21
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LbxMxEB61RUJcUHl2oURGQgKEttmXX8ckalVQU6qKooiLtWs7EIluqiY99Mbf4O_1l3TG2Y2y4sbFh7Utzc7Dns-eGQO8S52wCH10XGrEJoWsZKxVWcayLCspfCltKKQ9PhXHF8WXCZ9sAW9zYULQvq1mB_Xvy4N69ivEVl5d2n4bJ9Y_G48U4RjO-9uwjQraQvTm6oAu0trsGCX6i5Te040pEgG3q5TH9OweEicKRW9KbGxGoWb_vyvzxtbUDZvc2IeOduFx40CywYrQJ7Dl66fwcNxckT-DE4oMvGXzKUPXjgUxo44wOmpl3z-zkFvLcvZh9PVEDPKPDDs9m9WM0p9DJtjdn78L1tzbPIeLo8Nvo-O4eTIhtlzkS4pXk9rmssqcmAqL7kKCBmmFEwhVvE_QG-LceZ_LclqpXLhcySqhku6Jdb7Q-QvYqee13wOmReq4rjJdeFkoJ5BdGXoLnBCWdJmN4FPLO3O1qoxhAqJQwqyYbpDpJjDdyAiGxN71SKpqHT7Mr3-aRrZGp1Yh9YlH6opKZNrKqbUO10HpRWpFBO9JOIZsDyVgyyaFAAmmKlZmQM5GLhH1RbDfGYk2Y7vdrXhNY7MLk3EEnwSPswjerrtpJsWh1X5-E8bgisdTpSN4udKG9S-1ShWB7OhJ55-7PajgoaJ3o9Cv_nvma3iUBRXncaL2YWd5fePfoLe0rHpoIxPZgwfDw9Oz8144c8B2XChsz4c_esF67gFSIRTh
link.rule.ids 230,315,730,783,787,867,888,2109,12068,21400,24330,27936,27937,31731,31732,33756,33757,43322,43817,53804,53806
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LbxMxEB5BK0EvqLzK0gJGQgKEVt2XXyeUVq1SSAJCLerN2rUd2stuadIDt_4N_h6_pDOOE7pC4rr2Sva8PJ_nYYA3uRMWoY9Oa43YpJKNTLWq61TWdSOFr6UNjbTHEzE8qT6d8tN44TaLaZVLmxgMtess3ZHvFhyhAYGX4uPFz5RejaLoanxC4y6sU6sqBF_reweTr99WcQSKqi1LZZTYneX0uG5KaQl4duU8lb3jKHTt_9c23zqc-omTt06iw014EF1INljw_CHc8e0juDeOQfLHMKLcwF-smzJ07lhgNEoJo8tW9v2IhepaVrJ3-19GYlC-Zzjo2XnLqAA61IL9uf49YzFy8wRODg-O94dpfDQhtVyUc8pYk9qWsimcmAqLDkOGKmmFEwhWvM_QH-LceV_KetqoUrhSySajpu6Zdb7S5VNYa7vWPwOmRe64bgpdeVkpJ5RGZw3dB8JY0hU2gQ9L2pmLRW8MEzCFEmZBaYOUNoHSRiawR-RdzaS-1uFDd_nDRDUxOrcKV595XF3ViEJbObXWoSWUXuRWJPCWmGNI-5ADto5FBLhg6mNlBuRulBJxXwI7vZmoNbY_vGSviVo7M39lLIHXq2H6kzLRWt9dhTlo83iudAJbC2lYbQllXlRIpQRkT056e-6PtOdnoae3ImjO-fP_L-sV3B8ej0dmdDT5vA0bRRBknmZqB9bml1f-BTpI8-Zl1IIbh_oK4g
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwEB7BIq248H4EFjASEiCUNi-_jqWw2oV22QOLVlysxHahgk2rbXuAE3-Dv8cvYcZNqgZue40dyc7M2PNlvpkBeJY6YRH66LjUiE0KWclYq7KMZVlWUvhS2lBIe3wkDk6Kd6f8dKvVVyDt22raq7-f9erp18CtnJ_ZfssT6x-Ph4pwDOf9uZv0L8MVtNlEtEC9CSBQOK3NkVGiv0ipq25MfAS8tFIeU_M9XKIoFHWW2LqSQuX-_8_nrQuqS57cuo32r8Pndh9rEsq33mpZ9ezPf0o8XmijN-Ba46OywXrKTbjk61uwO26i8LdhROTDH2w2Yeg9sqBJqIaM_uayT4cspO-ynL0YfhiJQf6S4aBn05pRhnVINvvz6_eCNaGhO3Cy__bj8CBuujLElot8SZQ4qW0uq8yJibDokSRo81Y4gWjI-wQdLs6d97ksJ5XKhcuVrBKqGp9Y5wud34Wdelb7-8C0SB3XVaYLLwvlBMoiQ4eEE4iTLrMRvGoFY-br4hsmgBYlzFqiBiVqgkSNjOA1yW4zkwpnhwez8y-m-apGp1bh6hOPqysqkWkrJ9Y6PGqlF6kVETwnyRsybxSvLZssBVwwFcoyA_JnconAMoK9zkw0S9sdbnXHNMfCwmQc8S0h8CyCp5thepOobrWfrcIcPFR5qnQE99aqttlSq7ERyI4SdvbcHUHVCkXDG1V6cOE3n8Du8Zt9Mzo8ev8QrmbBlHicqD3YWZ6v_CP0zZbV42CFfwEDATPy
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Study+of+the+collagen+type+VI+alpha+3+%28COL6A3%29+gene+in+Parkinson%E2%80%99s+disease&rft.jtitle=BMC+neurology&rft.au=Chong-Yao+Jin&rft.au=Ran+Zheng&rft.au=Zhi-Hao+Lin&rft.au=Nai-Jia+Xue&rft.date=2021-05-08&rft.pub=BMC&rft.eissn=1471-2377&rft.volume=21&rft.issue=1&rft.spage=1&rft.epage=7&rft_id=info:doi/10.1186%2Fs12883-021-02215-7&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_91c89c30e7af4b629c7fccd8877e61c6
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2377&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2377&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2377&client=summon